I Martínez-Rodríguez, M de Arcocha-Torres, F J Gómez-de la Fuente, J Jiménez-Bonilla, A Sánchez-Salmón, N Martínez-Amador, V Mendi-Barcina, J Andrés-Pacheco, A Gutiérrez-González, M Pombo-López, A Bota-Bota, M Rodil-Gallego, A García-Ruiz, R Quirce
AIM: Our aim was to analyse the performance of [11 C]choline PET/CT in prostate cancer (PCa) surveillance, especially in patients with prostate specific antigen (PSA) < 1 ng/ml. MATERIAL AND METHODS: Three hundred and twenty-nine [11 C]choline PET/CT examinations from 191 patients (68.2 ± 7.2 years) submitted for PCa surveillance or biochemical recurrence were retrospectively evaluated. PSA at study was 13.0 ± 84.2 ng/ml...
November 22, 2022: Revista española de medicina nuclear e imagen molecular